Evidence map›Paper›PMID 31114241›Full record

ArticleOncoTargets and therapy2019

Large-cell neuroendocrine carcinoma of nasal cavity and paranasal sinuses after successful curative therapy: a case report and literature review.

Qin Zhao, Jinlong Wei, Chengbin Zhang, Lingbin Meng, Bin Wang, Ling Gao, Xin Jiang

Open access · goldAbstract readCase Reports
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Qin ZhaoDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun 130021, People's Republic of China.
Jinlong WeiDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun 130021, People's Republic of China.
Chengbin ZhangDepartment of pathology, the First Hospital of Jilin University, Changchun 130021, People's Republic of China.
Lingbin MengDepartment of Internal Medicine, Florida Hospital, Orlando, FL 32804, USA.
Bin WangDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun 130021, People's Republic of China.
Ling GaoDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun 130021, People's Republic of China.
Xin JiangDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun 130021, People's Republic of China.
Jilin University · CNAdventHealth Orlando · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report describes a 40-year-old male patient with symptoms affecting the nasal sinuses including nasal obstruction and olfactory anesthesia. Magnetic resonance imaging demonstrated that the tumor eroded the adjacent bone and bilateral frontal lobes. The biopsy sample of the left nasal mass was processed for both H&E staining and immunohistological staining for various markers. The final histological examination showed large-cell neuroendocrine carcinoma with poor differentiation. After a general evaluation, the patient was staged as cT4bN0M0. The patient was treated by combined radiotherapy and chemotherapy. The treatment yielded almost complete remission, and after 10 months of follow-up, no distant organ metastasis or recurrence in the primary tumor region was detected.We report this rare case and review the current literature of this tumor.

Indexed as

large-cell neuroendocrine carcinomanasal cavity and paranasal sinuses carcinomapathologyradiotherapy

Identifiers

PMID31114241
PMCPMC6489553
OpenAlexW2937504385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.